Calls grow louder to ease Swiss Covid-19 restrictions
A view of central Geneva on January 18. A semi-lockdown has been in place since mid-January in which non-essential businesses as well as restaurants and bars have been temporarily closed. Keystone / Laurent Gillieron
Cantonal authorities and business associations are putting mounting pressure on the government to ease pandemic restrictions. The federal government is due to meet on Wednesday to decide on the next steps.
This content was published on February 14, 2021 - 11:39
February 14, 2021 - 11:39
SonntagsZeitung/Keystone-SDA/sb
Calls are getting louder for the government to ease the current semi-lockdown in which non-essential businesses as well as restaurants and bars have been temporarily closed. The measures were imposed mid-January to curb the spread of Covid-19, amid more contagious virus strains.
Hundreds of protesters marched in Switzerland on Saturday against coronavirus restrictions after the health minister said the current restrictions will stay in place through the end of February.
By Reuters Staff
2 Min Read
Nurse Andre McFarlane prepares a dose of the Moderna s coronavirus disease (COVID-19) vaccine at the vaccination facility in the Bathgate Post Office, in the Bronx, in New York, U.S., January 10, 2021. Kevin Hagen/Pool via REUTERS
ZURICH (Reuters) - Contract drugmaker Lonza said on Monday it has begun manufacturing ingredients for Moderna Inc’s COVID-19 vaccine from the first of three new Swiss production lines and expects the initial batch to be ready by month’s end.
Last May, Lonza won a contract to manufacture active ingredients for Moderna’s mRNA vaccine, which now has approval in the United States, the European Union and in Britain, among other nations.